Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 90 articles:
HTML format
Text format



Single Articles


    June 2018
  1. HAN W, Cao F, Gao XJ, Wang HB, et al
    ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
    Int J Oncol. 2018 Jun 21. doi: 10.3892/ijo.2018.4450.
    PubMed     Text format     Abstract available


  2. NOWAK A, Dziegiel P
    Implications of nestin in breast cancer pathogenesis (Review).
    Int J Oncol. 2018 Jun 14. doi: 10.3892/ijo.2018.4441.
    PubMed     Text format     Abstract available


  3. CARLISLE SM, Hein DW
    Retrospective analysis of estrogen receptor 1 and Nacetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.
    Int J Oncol. 2018 Jun 11. doi: 10.3892/ijo.2018.4436.
    PubMed     Text format     Abstract available


    May 2018
  4. CHENG CC, Shi LH, Wang XJ, Wang SX, et al
    Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Int J Oncol. 2018 May 8. doi: 10.3892/ijo.2018.4399.
    PubMed     Text format     Abstract available


  5. KIM JY, Kim JC, Lee JY, Park MJ, et al
    Oct4 suppresses IRinduced premature senescence in breast cancer cells through STAT3- and NFkappaB-mediated IL24 production.
    Int J Oncol. 2018 May 2. doi: 10.3892/ijo.2018.4391.
    PubMed     Text format     Abstract available


    April 2018
  6. TAN Y, Zhou G, Wang X, Chen W, et al
    USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway.
    Int J Oncol. 2018 Apr 30. doi: 10.3892/ijo.2018.4387.
    PubMed     Text format     Abstract available


  7. ZHAO Y, Onda K, Yuan B, Tanaka S, et al
    Arsenic disulfideinduced apoptosis and its potential mechanism in two and threedimensionally cultured human breast cancer MCF7 cells.
    Int J Oncol. 2018 Apr 4. doi: 10.3892/ijo.2018.4357.
    PubMed     Text format     Abstract available


    March 2018
  8. ZHAO FQ, Misra Y, Li DB, Wadsworth MP, et al
    Differential expression of Oct3/4 in human breast cancer and normal tissues.
    Int J Oncol. 2018 Mar 29. doi: 10.3892/ijo.2018.4341.
    PubMed     Text format     Abstract available


  9. XIONG DD, Chen H, He RQ, Lan AH, et al
    MicroRNA-671-3p inhibits the development of breast cancer: A study based on in vitro experiments, in-house quantitative polymerase chain reaction and bioinformatics analysis.
    Int J Oncol. 2018 Mar 28. doi: 10.3892/ijo.2018.4339.
    PubMed     Text format     Abstract available


  10. COLIN C, Meyer M, Cerella C, Kleinclauss A, et al
    Biotinylation enhances the anticancer effects of 15dPGJ2 against breast cancer cells.
    Int J Oncol. 2018 Mar 28. doi: 10.3892/ijo.2018.4338.
    PubMed     Text format     Abstract available


  11. BUSCHMANN D, Gonzalez R, Kirchner B, Mazzone C, et al
    Glucocorticoid receptor overexpression slightly shifts microRNA expression patterns in triple-negative breast cancer.
    Int J Oncol. 2018 Mar 27. doi: 10.3892/ijo.2018.4336.
    PubMed     Text format     Abstract available


  12. LI Y, Zhang Y, Liu X, Wang M, et al
    Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
    Int J Oncol. 2018 Mar 23. doi: 10.3892/ijo.2018.4332.
    PubMed     Text format     Abstract available


  13. WU T, Song H, Xie D, Zhao B, et al
    Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
    Int J Oncol. 2018 Mar 20. doi: 10.3892/ijo.2018.4331.
    PubMed     Text format     Abstract available


  14. BEBEROK A, Wrzesniok D, Rok J, Rzepka Z, et al
    Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53/Bax/Bcl-2 signaling pathway.
    Int J Oncol. 2018 Mar 8. doi: 10.3892/ijo.2018.4310.
    PubMed     Text format     Abstract available


  15. DI D, Chen L, Guo Y, Wang L, et al
    BCSC-1 suppresses human breast cancer metastasis by inhibiting NF-kappaB signaling.
    Int J Oncol. 2018 Mar 7. doi: 10.3892/ijo.2018.4309.
    PubMed     Text format     Abstract available


  16. MIYAGAWA Y, Matsushita Y, Suzuki H, Komatsu M, et al
    Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer.
    Int J Oncol. 2018 Mar 5. doi: 10.3892/ijo.2018.4301.
    PubMed     Text format     Abstract available


    February 2018
  17. CASTELLANOS-ESPARZA YC, Wu S, Huang L, Buquet C, et al
    Synergistic promoting effects of pentoxifylline and simvastatin on the apoptosis of triple-negative MDA-MB-231 breast cancer cells.
    Int J Oncol. 2018 Feb 9. doi: 10.3892/ijo.2018.4272.
    PubMed     Text format     Abstract available


  18. MAXWELL T, Lee KS, Kim S, Nam KS, et al
    Arctigenin inhibits the activation of the mTOR pathway, resulting in autophagic cell death and decreased ER expression in ER-positive human breast cancer cells.
    Int J Oncol. 2018 Feb 9. doi: 10.3892/ijo.2018.4271.
    PubMed     Text format     Abstract available


  19. HAN Y, Fan S, Qin T, Yang J, et al
    Role of autophagy in breast cancer and breast cancer stem cells (Review).
    Int J Oncol. 2018 Feb 8. doi: 10.3892/ijo.2018.4270.
    PubMed     Text format     Abstract available


  20. YEN MC, Huang YC, Kan JY, Kuo PL, et al
    S100B expression in breast cancer as a predictive marker for cancer metastasis.
    Int J Oncol. 2018;52:433-440.
    PubMed     Text format     Abstract available


  21. NOWAK A, Grzegrzolka J, Kmiecik A, Piotrowska A, et al
    Role of nestin expression in angiogenesis and breast cancer progression.
    Int J Oncol. 2018;52:527-535.
    PubMed     Text format     Abstract available


    January 2018
  22. PENG F, Li Q, Sun JY, Luo Y, et al
    PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.
    Int J Oncol. 2018 Jan 30. doi: 10.3892/ijo.2018.4257.
    PubMed     Text format     Abstract available


  23. ZHONG R, Liang B, Xin R, Zhu X, et al
    Deoxycytidine kinase participates in the regulation of radiation-induced autophagy and apoptosis in breast cancer cells.
    Int J Oncol. 2018 Jan 22. doi: 10.3892/ijo.2018.4250.
    PubMed     Text format     Abstract available


  24. YOU KS, Yi YW, Kwak SJ, Seong YS, et al
    Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells.
    Int J Oncol. 2018 Jan 15. doi: 10.3892/ijo.2018.4244.
    PubMed     Text format     Abstract available


  25. ABSMAIER M, Napieralski R, Schuster T, Aubele M, et al
    PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.
    Int J Oncol. 2018 Jan 8. doi: 10.3892/ijo.2018.4241.
    PubMed     Text format     Abstract available


  26. CHANG LC, Hsieh MT, Yang JS, Lu CC, et al
    Effect of bis(hydroxymethyl) alkanoate curcuminoid derivative MTH-3 on cell cycle arrest, apoptotic and autophagic pathway in triple-negative breast adenocarcinoma MDA-MB-231 cells: An in vitro study.
    Int J Oncol. 2018;52:67-76.
    PubMed     Text format     Abstract available


  27. WANG Y, Yu X, Song H, Feng D, et al
    The STAT-ROS cycle extends IFNinduced cancer cell apoptosis.
    Int J Oncol. 2018;52:305-313.
    PubMed     Text format     Abstract available


    November 2017
  28. ALONSO-GONZALEZ C, Menendez-Menendez J, Gonzalez-Gonzalez A, Gonzalez A, et al
    Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF7 human breast cancer cells.
    Int J Oncol. 2017 Nov 28. doi: 10.3892/ijo.2017.4213.
    PubMed     Text format     Abstract available


  29. SONNENBLICK A, Salgado R, Brohee S, Zahavi T, et al
    p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.
    Int J Oncol. 2017 Nov 27. doi: 10.3892/ijo.2017.4212.
    PubMed     Text format     Abstract available


    October 2017
  30. RAMAN V, Fuentes Lorenzo JL, Stashenko EE, Levy M, et al
    Lippia origanoides extract induces cell cycle arrest and apoptosis and suppresses NF-kappaB signaling in triple-negative breast cancer cells.
    Int J Oncol. 2017 Oct 19. doi: 10.3892/ijo.2017.4169.
    PubMed     Text format     Abstract available


  31. BORAH N, Gunawardana S, Torres H, McDonnell S, et al
    5,6,7,3',4',5'-Hexamethoxyflavone inhibits growth of triple-negative breast cancer cells via suppression of MAPK and Akt signaling pathways and arresting cell cycle.
    Int J Oncol. 2017 Oct 13. doi: 10.3892/ijo.2017.4157.
    PubMed     Text format     Abstract available


  32. RATAJCZAK-WIELGOMAS K, Grzegrzolka J, Piotrowska A, Matkowski R, et al
    Expression of periostin in breast cancer cells.
    Int J Oncol. 2017;51:1300-1310.
    PubMed     Text format     Abstract available


  33. YIN H, Zhu Q, Liu M, Tu G, et al
    GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis.
    Int J Oncol. 2017;51:1191-1198.
    PubMed     Text format     Abstract available


  34. PHILLIPS SL, Williams CB, Zambrano JN, Williams CJ, et al
    Connexin 43 in the development and progression of breast cancer: What's the connection? (Review).
    Int J Oncol. 2017;51:1005-1013.
    PubMed     Text format     Abstract available


    September 2017
  35. YANG L, Li Y, Shen E, Cao F, et al
    NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells.
    Int J Oncol. 2017 Sep 21. doi: 10.3892/ijo.2017.4130.
    PubMed     Text format     Abstract available


  36. ESPINOZA-SANCHEZ NA, Vadillo E, Balandran JC, Monroy-Garcia A, et al
    Evidence of lateral transmission of aggressive features between different types of breast cancer cells.
    Int J Oncol. 2017 Sep 19. doi: 10.3892/ijo.2017.4128.
    PubMed     Text format     Abstract available


  37. CALAF GM, Roy D
    Metastatic genes targeted by an antioxidant in an established radiation- and estrogen-breast cancer model.
    Int J Oncol. 2017 Sep 14. doi: 10.3892/ijo.2017.4125.
    PubMed     Text format     Abstract available


  38. D'ANGELO S, Martino E, Ilisso CP, Bagarolo ML, et al
    Pro-oxidant and pro-apoptotic activity of polyphenol extract from Annurca apple and its underlying mechanisms in human breast cancer cells.
    Int J Oncol. 2017;51:939-948.
    PubMed     Text format     Abstract available


  39. OBAYASHI S, Horiguchi J, Higuchi T, Katayama A, et al
    Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.
    Int J Oncol. 2017;51:781-790.
    PubMed     Text format     Abstract available



  40. [Corrigendum] Transcriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications.
    Int J Oncol. 2017;51:997-0.
    PubMed     Text format     Abstract available


    August 2017
  41. ILKOVICOVA L, Trost N, Szentpeteriova E, Solar P, et al
    Overexpression of the erythropoietin receptor in RAMA 37 breast cancer cells alters cell growth and sensitivity to tamoxifen.
    Int J Oncol. 2017;51:737-746.
    PubMed     Text format     Abstract available


    July 2017
  42. WANG Y, Wang H, Ding Y, Li Y, et al
    N-peptide of vMIP- reverses paclitaxel-resistance by regulating miRNA-335 in breast cancer.
    Int J Oncol. 2017 Jul 19. doi: 10.3892/ijo.2017.4076.
    PubMed     Text format     Abstract available


  43. LI SJ, Liu CS, Li HJ, Li Y, et al
    A novel engineered interferon-alpha hybrid molecule increases anticancer efficacy of doxorubicin in breast cancer chemotherapy.
    Int J Oncol. 2017 Jul 3. doi: 10.3892/ijo.2017.4062.
    PubMed     Text format     Abstract available


    June 2017
  44. KIM DH, Sung B, Kim JA, Kang YJ, et al
    HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.
    Int J Oncol. 2017 Jun 27. doi: 10.3892/ijo.2017.4058.
    PubMed     Text format     Abstract available


  45. NOWAK A, Grzegrzolka J, Paprocka M, Piotrowska A, et al
    Nestin-positive microvessel density is an independent prognostic factor in breast cancer.
    Int J Oncol. 2017 Jun 26. doi: 10.3892/ijo.2017.4057.
    PubMed     Text format     Abstract available


  46. YAO M, Yuan B, Wang X, Sato A, et al
    Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7.
    Int J Oncol. 2017 Jun 23. doi: 10.3892/ijo.2017.4052.
    PubMed     Text format     Abstract available


    May 2017
  47. LIANG N, Li Y, Chung HY
    Two natural eudesmane-type sesquiterpenes from Laggera alata inhibit angiogenesis and suppress breast cancer cell migration through VEGF- and Angiopoietin 2-mediated signaling pathways.
    Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4004.
    PubMed     Text format     Abstract available


  48. LINDSTEN T, Hedbrant A, Ramberg A, Wijkander J, et al
    Effect of macrophages on breast cancer cell proliferation, and on expression of hormone receptors, uPAR and HER-2.
    Int J Oncol. 2017 May 11. doi: 10.3892/ijo.2017.3996.
    PubMed     Text format     Abstract available


  49. DING Y, Zhang C, Zhang J, Zhang N, et al
    miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-beta1 expression.
    Int J Oncol. 2017;50:1701-1710.
    PubMed     Text format     Abstract available


  50. NGUYEN CH, Huttary N, Atanasov AG, Chatuphonprasert W, et al
    Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model.
    Int J Oncol. 2017;50:1879-1888.
    PubMed     Text format     Abstract available


    April 2017
  51. MCDERMOTT MSJ, Canonici A, Ivers L, Browne BC, et al
    Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cells.
    Int J Oncol. 2017 Apr 26. doi: 10.3892/ijo.2017.3976.
    PubMed     Text format     Abstract available


    March 2017
  52. XI J, Feng J, Li Q, Li X, et al
    The long non-coding RNA lncFOXO1 suppresses growth of human breast cancer cells through association with BAP1.
    Int J Oncol. 2017 Mar 24. doi: 10.3892/ijo.2017.3933.
    PubMed     Text format     Abstract available


  53. OKAMOTO K, Tanaka Y, Tsuneoka M
    SF-KDM2A binds to ribosomal RNA gene promoter, reduces H4K20me3 level, and elevates ribosomal RNA transcription in breast cancer cells.
    Int J Oncol. 2017 Mar 10. doi: 10.3892/ijo.2017.3908.
    PubMed     Text format     Abstract available


  54. GIL EY, Jo UH, Jeong H, Whang YM, et al
    [Corrigendum] Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer.
    Int J Oncol. 2017 Mar 7. doi: 10.3892/ijo.2017.3900.
    PubMed     Text format     Abstract available


  55. ZHENG X, Wang C, Xing Y, Chen S, et al
    SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells.
    Int J Oncol. 2017;50:893-902.
    PubMed     Text format     Abstract available


    February 2017
  56. PANAGOPOULOS V, Leach DA, Zinonos I, Ponomarev V, et al
    Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.
    Int J Oncol. 2017 Feb 20. doi: 10.3892/ijo.2017.3883.
    PubMed     Text format     Abstract available


  57. LANGO-CHAVARRIA M, Chimal-Ramirez GK, Ruiz-Tachiquin ME, Espinoza-Sanchez NA, et al
    A 22q11.2 amplification in the region encoding microRNA-650 correlates with the epithelial to mesenchymal transition in breast cancer primary cultures of Mexican patients.
    Int J Oncol. 2017;50:432-440.
    PubMed     Text format     Abstract available


  58. GUERRIERO E, Sorice A, Capone F, Storti G, et al
    Combining doxorubicin with a phenolic extract from flaxseed oil: Evaluation of the effect on two breast cancer cell lines.
    Int J Oncol. 2017;50:468-476.
    PubMed     Text format     Abstract available


    January 2017
  59. TRIANTAFILLU UL, Park S, Klaassen NL, Raddatz AD, et al
    Fluid shear stress induces cancer stem cell-like phenotype in MCF7 breast cancer cell line without inducing epithelial to mesenchymal transition.
    Int J Oncol. 2017 Jan 30. doi: 10.3892/ijo.2017.3865.
    PubMed     Text format     Abstract available


  60. JIANG W, Li X, Li T, Wang H, et al
    Repositioning of amprenavir as a novel extracellular signal-regulated kinase-2 inhibitor and apoptosis inducer in MCF-7 human breast cancer.
    Int J Oncol. 2017 Jan 24. doi: 10.3892/ijo.2017.3860.
    PubMed     Text format     Abstract available


    December 2016
  61. MAXWELL T, Chun SY, Lee KS, Kim S, et al
    The anti-metastatic effects of the phytoestrogen arctigenin on human breast cancer cell lines regardless of the status of ER expression.
    Int J Oncol. 2016 Dec 29. doi: 10.3892/ijo.2016.3825.
    PubMed     Text format     Abstract available


  62. NAKAYAMA J, Ito E, Fujimoto J, Watanabe S, et al
    Comparative analysis of gene regulatory networks of highly metastatic breast cancer cells established by orthotopic transplantation and intra-circulation injection.
    Int J Oncol. 2016 Dec 16. doi: 10.3892/ijo.2016.3809.
    PubMed     Text format     Abstract available


  63. PARK JH, Kim HK, Jung H, Kim KH, et al
    NecroX-5 prevents breast cancer metastasis by AKT inhibition via reducing intracellular calcium levels.
    Int J Oncol. 2016 Dec 5. doi: 10.3892/ijo.2016.3789.
    PubMed     Text format     Abstract available


    November 2016
  64. SHYAMASUNDAR S, Lim JP, Bay BH
    miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1.
    Int J Oncol. 2016 Nov 7. doi: 10.3892/ijo.2016.3761.
    PubMed     Text format     Abstract available


  65. GOMULKIEWICZ A, Jablonska K, Pula B, Grzegrzolka J, et al
    Expression of metallothionein 3 in ductal breast cancer.
    Int J Oncol. 2016 Nov 4. doi: 10.3892/ijo.2016.3759.
    PubMed     Text format     Abstract available


    October 2016
  66. ZHOU H, Li J, Zhang Z, Ye R, et al
    RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Int J Oncol. 2016 Oct 5. doi: 10.3892/ijo.2016.3718.
    PubMed     Text format     Abstract available


    September 2016
  67. MEJIA-RANGEL J, Cordova E, Orozco L, Ventura-Gallegos JL, et al
    Pro-adhesive phenotype of normal endothelial cells responding to metastatic breast cancer cell conditioned medium is linked to NFkappaB-mediated transcriptomic regulation.
    Int J Oncol. 2016 Sep 26. doi: 10.3892/ijo.2016.3705.
    PubMed     Text format     Abstract available


  68. DING J, Guo C, Hu P, Chen J, et al
    CSF1 is involved in breast cancer progression through inducing monocyte differentiation and homing.
    Int J Oncol. 2016 Sep 6. doi: 10.3892/ijo.2016.3680.
    PubMed     Text format     Abstract available


  69. LIU ZG, Tang J, Chen Z, Zhang H, et al
    The novel mTORC1/2 dual inhibitor INK128 enhances radiosensitivity of breast cancer cell line MCF-7.
    Int J Oncol. 2016;49:1039-45.
    PubMed     Text format     Abstract available


  70. ZHAO Q, Zhao M, Parris AB, Xing Y, et al
    Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells.
    Int J Oncol. 2016;49:1203-10.
    PubMed     Text format     Abstract available


  71. PARK JH, Cho YY, Yoon SW, Park B, et al
    Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-kappaB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells.
    Int J Oncol. 2016;49:1230-40.
    PubMed     Text format     Abstract available


  72. GALLARDO M, Calaf GM
    Curcumin inhibits invasive capabilities through epithelial mesenchymal transition in breast cancer cell lines.
    Int J Oncol. 2016;49:1019-27.
    PubMed     Text format     Abstract available


  73. IBRAHIM T, Liverani C, Mercatali L, Sacanna E, et al
    [Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines.
    Int J Oncol. 2016;49:1260.
    PubMed     Text format     Abstract available


  74. CHA J, Roomi MW, Kalinovsky T, Niedzwiecki A, et al
    Lipoprotein(a) and vitamin C impair development of breast cancer tumors in Lp(a)+; Gulo-/- mice.
    Int J Oncol. 2016;49:895-902.
    PubMed     Text format     Abstract available


  75. PARK HJ, Kim MK, Choi KS, Jeong JW, et al
    Neuromedin B receptor antagonism inhibits migration, invasion, and epithelial-mesenchymal transition of breast cancer cells.
    Int J Oncol. 2016;49:934-42.
    PubMed     Text format     Abstract available


    August 2016
  76. MIYAHARA K, Kazama H, Kokuba H, Komatsu S, et al
    Targeting bortezomib-induced aggresome formation using vinorelbine enhances the cytotoxic effect along with ER stress loading in breast cancer cell lines.
    Int J Oncol. 2016 Aug 29. doi: 10.3892/ijo.2016.3673.
    PubMed     Text format     Abstract available


  77. HE DX, Zhang GY, Gu XT, Mao AQ, et al
    Genome-wide profiling of long non-coding RNA expression patterns in anthracycline-resistant breast cancer cells.
    Int J Oncol. 2016 Aug 22. doi: 10.3892/ijo.2016.3665.
    PubMed     Text format     Abstract available


  78. KARIYA Y, Tatsuta T, Sugawara S, Kariya Y, et al
    RNase activity of sialic acid-binding lectin from bullfrog eggs drives antitumor effect via the activation of p38 MAPK to caspase-3/7 signaling pathway in human breast cancer cells.
    Int J Oncol. 2016 Aug 11. doi: 10.3892/ijo.2016.3656.
    PubMed     Text format     Abstract available


  79. CHOI YJ, Heo K, Park HS, Yang KM, et al
    The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions.
    Int J Oncol. 2016 Aug 3. doi: 10.3892/ijo.2016.3647.
    PubMed     Text format     Abstract available


    July 2016
  80. XU H, Wu K, Tian Y, Liu Q, et al
    CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer.
    Int J Oncol. 2016 Jul 29. doi: 10.3892/ijo.2016.3639.
    PubMed     Text format     Abstract available


  81. SULAIMAN NB, Mohan CD, Basappa S, Pandey V, et al
    An azaspirane derivative suppresses growth and induces apoptosis of ER-positive and ER-negative breast cancer cells through the modulation of JAK2/STAT3 signaling pathway.
    Int J Oncol. 2016 Jul 6. doi: 10.3892/ijo.2016.3615.
    PubMed     Text format     Abstract available


    June 2016
  82. KIM B, Kim YC, Park B
    Pomolic acid inhibits metastasis of HER2 overexpressing breast cancer cells through inactivation of the ERK pathway.
    Int J Oncol. 2016 Jun 7. doi: 10.3892/ijo.2016.3568.
    PubMed     Text format     Abstract available


  83. PILCO-FERRETO N, Calaf GM
    Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines.
    Int J Oncol. 2016 Jun 3. doi: 10.3892/ijo.2016.3558.
    PubMed     Text format     Abstract available


    May 2016
  84. PARK JH, Jang M, Tarhan YE, Katagiri T, et al
    Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy.
    Int J Oncol. 2016 May 27. doi: 10.3892/ijo.2016.3540.
    PubMed     Text format     Abstract available


  85. YAMAGUCHI M, Osuka S, Weitzmann MN, Shoji M, et al
    Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro.
    Int J Oncol. 2016 May 24. doi: 10.3892/ijo.2016.3538.
    PubMed     Text format     Abstract available


  86. MENG X, Hu B, Hossain MM, Chen G, et al
    ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation.
    Int J Oncol. 2016 May 24. doi: 10.3892/ijo.2016.3536.
    PubMed     Text format     Abstract available


  87. CHEN SY, Zheng XW, Cai JX, Zhang WP, et al
    Histone deacetylase inhibitor reverses multidrug resistance by attenuating the nucleophosmin level through PI3K/Akt pathway in breast cancer.
    Int J Oncol. 2016 May 17. doi: 10.3892/ijo.2016.3528.
    PubMed     Text format     Abstract available


  88. WOODMAN N, Pinder SE, Tajadura V, Le Bourhis X, et al
    Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.
    Int J Oncol. 2016 May 13. doi: 10.3892/ijo.2016.3521.
    PubMed     Text format     Abstract available


  89. KWON YS, Lee KS, Chun SY, Jang TJ, et al
    Suppressive effects of a proton beam on tumor growth and lung metastasis through the inhibition of metastatic gene expression in 4T1 orthotopic breast cancer model.
    Int J Oncol. 2016 May 13. doi: 10.3892/ijo.2016.3520.
    PubMed     Text format     Abstract available


  90. GARCIA EP, Tiscornia I, Libisch G, Trajtenberg F, et al
    MUC5B silencing reduces chemo-resistance of MCF-7 breast tumor cells and impairs maturation of dendritic cells.
    Int J Oncol. 2016;48:2113-23.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: